Karolinska Development’s portfolio company Promimic has elected Tord Lendau as Chairman of the Board of Directors, and Håkan Krook and Patrik Sjöstrand as Non-executive Directors.
Tord Lendau brings to Promimic more than 32 years’ of international leadership and board experience from innovative, rapid growth companies. Most recently, he was General Manager at Sandvik MedTech, and has previously held senior executive roles at Synectics, Medtronic, ArthroCare and Diamyd. Other current assignments include Chairman of the board of Encare AB, Scibase AB, Hubbster AB and Actea Consulting AB, and he is a Board member and Chairman of the Audit Committee of Vitrolife. Mr Lendau studied Industrial Engineering (I-Linjen) at Linköping University.
Håkan Krook holds the position as Fund Manager at Chalmers Ventures (March 2013-present) and was previously CEO of ALMI Invest Västsverige AB (2009-2013). Mr Krook is an experienced investor and entrepreneur and brings more than 20 years’ experience from advising fast-growing companies. He holds an MSc in Business and Economics from Karlstad University.
Patrik Sjöstrand has been Investment Manager at Almi Invest AB since October 2015, and is a Board member of winningtemp AB, Lumina Adhesives AB, Metrum AB, Monivent AB and Stayble Therapeutics AB. Prior to this he was Chief Operational Officer at Orzone AB (2010-2015). He holds a BSc in Construction Engineering from Chalmers University of Technology.
Ulf Brogren, CEO of Promimic AB, said: “We are delighted to welcome Tord, Håkan and Patrik to the Board of Promimic. The Company has made significant progress during the past 12 months based on the development and commercialisation of our innovative HAnano Surface technology for coating medical implants. The considerable experience that the new board brings will be invaluable as we execute our growth strategy in the coming years.”